Skip to main content
Clinical Trials/NCT05281380
NCT05281380
Recruiting
Not Applicable

Vitamin Insufficiency After Surgery for Esophagogastric Neoplasms: a Prospective Intervention Study

Zuyderland Medisch Centrum1 site in 1 country248 target enrollmentDecember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal Cancer
Sponsor
Zuyderland Medisch Centrum
Enrollment
248
Locations
1
Primary Endpoint
Micronutrient deficiency yes or no.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Rationale: Esophageal cancer and gastric cancer are among the top ten most common cancers worldwide. Both diseases have major impact on the nutritional status of patients and their quality of life. Studies investigating post-operative nutritional status are limited and postoperative identification and treatment of micro- and macronutritional deficiencies are currently lacking in (inter-)national guidelines.

Objective: To identify and target vitamin deficiencies after surgery for esophagogastric neoplasms.

Study design: Single centre intervention study. Study population: Patients aged 18 years and older that underwent esophagectomy or (sub- )total gastrectomy for esophagogastric neoplasms.

Intervention (if applicable): Two tailormade supplements for patients; one for that underwent esophagectomy and one for (sub-)total gastrectomy.

Main study parameters/endpoints: Baseline micronutrient deficiency measurements and after 6, 12, 24 months supplementation,.

Secondary study parameters/ endpoints: Occurrence of exocrine pancreatic insufficiency (n,%), occurrence of diarrhoea (n,%), steatorrhea (n,%), bloating (n,%), time between surgery and start of supplementation (mean in months), quality of life experienced (questionnaires) at baseline and after 6, 12, 24 months supplementation.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In this study, no health-related risks are present for participants due to the administration of supplementation that is already used as in clinical practice.

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
November 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zuyderland Medisch Centrum
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A potential subject who meets any of the following criteria will be included for participation in this study:
  • Patients ≥18 years of age who underwent an esophagectomy or (sub)total gastrectomy for malignancy with no signs of postoperative recurrence of disease.
  • Written voluntary informed consent (IC).

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Patients that underwent a wedge resection of the stomach
  • Malignant disease recurrence
  • Metastases
  • Patients that are not capable to take supplementation due to altered mental status or swallow difficulties
  • No signed informed consent
  • Patients who are receiving chemotherapy
  • Patients with high vitamin status at baseline

Outcomes

Primary Outcomes

Micronutrient deficiency yes or no.

Time Frame: 2 years

Micronutrient deficiency yes or no.

Secondary Outcomes

  • The incidence of exocrine pancreatic insufficiency(2 years)
  • To measure quality of life post-operative(2 years)

Study Sites (1)

Loading locations...

Similar Trials